832735-54-3 Usage
General Description
2-Benzyloxypyridine-5-boronic acid, pinacol ester is a chemical compound that belongs to the class of boronic acid esters. It is commonly used as a reagent in Suzuki-Miyaura coupling reactions, which is a widely used method for the formation of carbon-carbon bonds in organic synthesis. 2-BENZYLOXYPYRIDINE-5-BORONIC ACID, PINACOL ESTER is known for its high reactivity and selectivity, making it an important tool for the construction of complex organic molecules in pharmaceutical and agrochemical research. Additionally, the pinacol ester group provides stability and solubility, making it a versatile building block in synthetic chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 832735-54-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,3,2,7,3 and 5 respectively; the second part has 2 digits, 5 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 832735-54:
(8*8)+(7*3)+(6*2)+(5*7)+(4*3)+(3*5)+(2*5)+(1*4)=173
173 % 10 = 3
So 832735-54-3 is a valid CAS Registry Number.
InChI:InChI=1/C18H22BNO3/c1-17(2)18(3,4)23-19(22-17)15-10-11-16(20-12-15)21-13-14-8-6-5-7-9-14/h5-12H,13H2,1-4H3
832735-54-3Relevant articles and documents
ION CHANNEL MODULATORS
-
, (2019/12/25)
The present invention is directed to, in part, fused heteroaryl compounds and compositions useful for preventing and/or treating a disease or condition relating to aberrant function of a voltage-gated, sodium ion channel, for example, abnormal late/persistent sodium current. Methods of treating a disease or condition relating to aberrant function of a sodium ion channel including neurological disorders (e.g., Dravet syndrome, epilepsy), pain, and neuromuscular disorders are also provided herein.
PYRROLIDINONE DERIVATIVES AS GPR119 MODULATORS FOR THE TREATMENT OF DIABETES, OBESITY, DYSLIPIDEMIA AND RELATED DISORDERS
-
Page/Page column 44; 46, (2014/05/07)
The present invention relates to pyrrolidinone derivatives of formula (I). The pyrrolidinone derivatives of formula (I) are GPR119 modulators and useful for the prevention and/or treatment of diabetes, obesity, dyslipidemia and related disorders. The invention furthermore relates to the use of pyrrolidinone derivatives as active ingredients in pharmaceuticals, and pharmaceutical compositions comprising them.